Publication | Closed Access

Design, synthesis, and evaluation of novel 2-substituted-4-aryl-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,5]oxazocin-5-ones as NK1 antagonists

Medicinal ChemistryMedicineDrug DiscoveryNk1 AntagonistsHeterocycle ChemistryPharmacologyPharmaceutical ChemistrySynthetic ChemistryBiomolecular Engineering